Literature DB >> 27064076

Protein folding alterations in amyotrophic lateral sclerosis.

Sonam Parakh1, Julie D Atkin2.   

Abstract

Protein misfolding leads to the formation of aggregated proteins and protein inclusions, which are associated with synaptic loss and neuronal death in neurodegenerative diseases. Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that targets motor neurons in the brain, brainstem and spinal cord. Several proteins misfold and are associated either genetically or pathologically in ALS, including superoxide dismutase 1 (SOD1), Tar DNA binding protein-43 (TDP-43), Ubiquilin-2, p62, VCP, and dipeptide repeat proteins produced by unconventional repeat associated non-ATG translation of the repeat expansion in C9ORF72. Chaperone proteins, including heat shock proteins (Hsp׳s) and the protein disulphide isomerase (PDI) family, assist in protein folding and therefore can prevent protein misfolding, and have been implicated as being protective in ALS. In this review we provide an overview of the current literature regarding the molecular mechanisms of protein misfolding and aggregation in ALS, and the role of chaperones as potential targets for therapeutic intervention. This article is part of a Special Issue entitled SI:ER stress.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; C9ORF72; Disulphide bonds; ER stress; FUS; Protein disulphide isomerase (PDI); Protein misfolding; Superoxide dismutase 1 (SOD1); TDP-43

Mesh:

Substances:

Year:  2016        PMID: 27064076     DOI: 10.1016/j.brainres.2016.04.010

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  35 in total

Review 1.  The bowel and beyond: the enteric nervous system in neurological disorders.

Authors:  Meenakshi Rao; Michael D Gershon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-07-20       Impact factor: 46.802

2.  Structural Rearrangement upon Fragmentation of the Stability Core of the ALS-Linked Protein TDP-43.

Authors:  Brittany R Morgan; Jill A Zitzewitz; Francesca Massi
Journal:  Biophys J       Date:  2017-08-08       Impact factor: 4.033

3.  Klotho Is Neuroprotective in the Superoxide Dismutase (SOD1G93A) Mouse Model of ALS.

Authors:  Ella Zeldich; Ci-Di Chen; Emma Boden; Bryce Howat; Jason S Nasse; Dean Zeldich; Anthony G Lambert; Andrea Yuste; Jonathan D Cherry; Rebecca M Mathias; Qicheng Ma; Nelson C Lau; Ann C McKee; Theo Hatzipetros; Carmela R Abraham
Journal:  J Mol Neurosci       Date:  2019-06-27       Impact factor: 3.444

4.  ALS-associated KIF5A mutations abolish autoinhibition resulting in a toxic gain of function.

Authors:  Desiree M Baron; Adam R Fenton; Sara Saez-Atienzar; Anthony Giampetruzzi; Aparna Sreeram; Pamela J Keagle; Victoria R Doocy; Nathan J Smith; Eric W Danielson; Megan Andresano; Mary C McCormack; Jaqueline Garcia; Valérie Bercier; Ludo Van Den Bosch; Jonathan R Brent; Claudia Fallini; Bryan J Traynor; Erika L F Holzbaur; John E Landers
Journal:  Cell Rep       Date:  2022-04-05       Impact factor: 9.995

Review 5.  Could Sirtuin Activities Modify ALS Onset and Progression?

Authors:  Bor Luen Tang
Journal:  Cell Mol Neurobiol       Date:  2016-12-10       Impact factor: 5.046

Review 6.  Liver X receptors: from cholesterol regulation to neuroprotection-a new barrier against neurodegeneration in amyotrophic lateral sclerosis?

Authors:  Kevin Mouzat; Cédric Raoul; Anne Polge; Jovana Kantar; William Camu; Serge Lumbroso
Journal:  Cell Mol Life Sci       Date:  2016-08-10       Impact factor: 9.261

7.  Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial).

Authors:  Eleonora Dalla Bella; Irene Tramacere; Giovanni Antonini; Giuseppe Borghero; Margherita Capasso; Claudia Caponnetto; Adriano Chiò; Massimo Corbo; Roberto Eleopra; Massimiliano Filosto; Fabio Giannini; Enrico Granieri; Vincenzo La Bella; Christian Lunetta; Jessica Mandrioli; Letizia Mazzini; Sonia Messina; Maria Rosaria Monsurrò; Gabriele Mora; Nilo Riva; Romana Rizzi; Gabriele Siciliano; Vincenzo Silani; Isabella Simone; Gianni Sorarù; Paolo Volanti; Giuseppe Lauria
Journal:  BMJ Open       Date:  2017-08-11       Impact factor: 2.692

Review 8.  DNA damage as a mechanism of neurodegeneration in ALS and a contributor to astrocyte toxicity.

Authors:  Jannigje Rachel Kok; Nelma M Palminha; Cleide Dos Santos Souza; Sherif F El-Khamisy; Laura Ferraiuolo
Journal:  Cell Mol Life Sci       Date:  2021-06-26       Impact factor: 9.261

9.  Viral vector gene delivery of the novel chaperone protein SRCP1 to modify insoluble protein in in vitro and in vivo models of ALS.

Authors:  Ian W Luecke; Gloria Lin; Stephanie Santarriaga; K Matthew Scaglione; Allison D Ebert
Journal:  Gene Ther       Date:  2021-07-08       Impact factor: 5.250

Review 10.  The Emerging Role of the Major Histocompatibility Complex Class I in Amyotrophic Lateral Sclerosis.

Authors:  Gabriela Bortolança Chiarotto; Giovanni Nardo; Maria Chiara Trolese; Marcondes Cavalcante França; Caterina Bendotti; Alexandre Leite Rodrigues de Oliveira
Journal:  Int J Mol Sci       Date:  2017-11-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.